|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Operating expenses: | |||||
| Cost of revenues (excluding depreciation and amortization) | |||||
| General and administrative expenses | |||||
| Selling and marketing expenses | |||||
| Research and development expenses | |||||
| Depreciation and amortization | |||||
| Acquisition-related expenses | |||||
| Restructuring expenses | |||||
| Total operating expenses | |||||
| Income / (loss) from operations | |||||
| Interest expenses, net | |||||
| Other expenses / (income) | |||||
| Total other expenses | |||||
| Loss before income taxes | |||||
| Income tax (benefit) / provision | |||||
| Net loss | |||||
| Other comprehensive (income) / loss: | |||||
| Foreign currency translation adjustment | |||||
| Total comprehensive loss | |||||
| Net loss per share | |||||
| Net loss available to common stockholders | |||||
| Basic loss per share | |||||
| Diluted loss per share | |||||
| Weighted average number of shares used to compute net loss per share | |||||
| Basic | |||||
| Diluted | |||||
Loading...